Sample overview
| Project Name |
TARGET-ALL
|
| GSE ID |
GSE196214
|
| GSM ID |
GSM5862814
|
| Cell Line |
None
|
| Tissue type |
Bone Marrow
|
| Disease Type |
Relapse
|
| PMID |
\
|
| Initial gene number |
33538
|
| Initial cell number |
5334
|
| Post-QC gene number |
5490
|
| Post-QC cell number |
1123
|
Bulk-to-ScRNA-seq Label Transfer
Bulk phenotype-associated subpopulations
Reference-Based Annotation
Differentially expressed genes
Overall Survival : Cluster
vs
There are no results of the analysis here
Overall Survival : Cluster
vs ( + )
There are no results of the analysis here
Clinical Stage : Cluster
vs
There
are no results of the analysis here
Tumor Size : Cluster
vs
There
are no results of the analysis here
Lymph Node Involvement : Cluster
vs
There
are no results of the analysis here
Distant Metastasis : Cluster
vs
There
are no results of the analysis here
Cell-Cell communications ( Survival-Associated Subpopulations Across Cell Types )
Cell Population Signaling and Communication
Ligand-Receptor-Mediated Cell-Cell Interactions
| Sending Cell Type |
Ligand |
Receiving Cell Type |
Receptor |
Score |
P-value |
Pathway Name |
Function |
Evidence |
| HSC(Nos)_source |
LGALS9_ligand |
CD4+,T-cells(Nos)_target |
PTPRC_receptor |
5.868e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| Monocytes(Nos)_source |
LGALS9_ligand |
CD4+,T-cells(Nos)_target |
PTPRC_receptor |
1.319e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| Monocytes(Nos)_source |
LGALS9_ligand |
HSC(Nos)_target |
PTPRC_receptor |
2.647e-03 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| HSC(Nos)_source |
LGALS9_ligand |
Monocytes(Nos)_target |
PTPRC_receptor |
5.361e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| Monocytes(Nos)_source |
LGALS9_ligand |
Monocytes(Nos)_target |
PTPRC_receptor |
1.226e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| HSC(Nos)_source |
LGALS9_ligand |
NK,cells(Nos)_target |
PTPRC_receptor |
8.620e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| Monocytes(Nos)_source |
LGALS9_ligand |
NK,cells(Nos)_target |
PTPRC_receptor |
1.875e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 30120235 |
| Monocytes(Nos)_source |
LGALS9_ligand |
HSC(Nos)_target |
CD44_receptor |
6.446e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 25065622 |
| HSC(Nos)_source |
LGALS9_ligand |
Monocytes(Nos)_target |
CD44_receptor |
2.900e-04 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 25065622 |
| Monocytes(Nos)_source |
LGALS9_ligand |
Monocytes(Nos)_target |
CD44_receptor |
7.220e-05 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 25065622 |
| Monocytes(Nos)_source |
LGALS9_ligand |
NK,cells(Nos)_target |
CD44_receptor |
1.849e-05 |
0.0 |
GALECTIN |
Secreted Signaling |
PMID: 25065622 |
| CD4+,T-cells(Nos)_source |
ADGRE5_ligand |
Monocytes(Nos)_target |
CD55_receptor |
8.842e-06 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| HSC(Nos)_source |
ADGRE5_ligand |
Monocytes(Nos)_target |
CD55_receptor |
4.230e-04 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| Monocytes(Nos)_source |
ADGRE5_ligand |
Monocytes(Nos)_target |
CD55_receptor |
2.248e-05 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| NK,cells(Nos)_source |
ADGRE5_ligand |
Monocytes(Nos)_target |
CD55_receptor |
2.197e-05 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| CD4+,T-cells(Nos)_source |
ADGRE5_ligand |
NK,cells(Nos)_target |
CD55_receptor |
7.956e-06 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| HSC(Nos)_source |
ADGRE5_ligand |
NK,cells(Nos)_target |
CD55_receptor |
3.810e-04 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| Monocytes(Nos)_source |
ADGRE5_ligand |
NK,cells(Nos)_target |
CD55_receptor |
2.035e-05 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| NK,cells(Nos)_source |
ADGRE5_ligand |
NK,cells(Nos)_target |
CD55_receptor |
1.985e-05 |
0.0 |
ADGRE5 |
Cell-Cell Contact |
PMID: 11297558 |
| HSC(Nos)_source |
ALCAM_ligand |
HSC(Nos)_target |
CD6_receptor |
4.204e-04 |
0.0 |
ALCAM |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
CD6_ligand |
HSC(Nos)_target |
ALCAM_receptor |
4.204e-04 |
0.0 |
CD6 |
Cell-Cell Contact |
PMID: 23602662 |
| HSC(Nos)_source |
CD99_ligand |
HSC(Nos)_target |
CD99_receptor |
4.564e-01 |
0.0 |
CD99 |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
CDH2_ligand |
HSC(Nos)_target |
CDH2_receptor |
2.549e-04 |
0.0 |
CDH |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
ICAM2_ligand |
Monocytes(Nos)_target |
ITGAL_ITGB2_receptor |
1.503e-04 |
0.0 |
ICAM |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
ICAM2_ligand |
NK,cells(Nos)_target |
ITGAL_ITGB2_receptor |
1.894e-04 |
0.0 |
ICAM |
Cell-Cell Contact |
KEGG: hsa04514 |
| Monocytes(Nos)_source |
ITGB2_ligand |
HSC(Nos)_target |
ICAM2_receptor |
3.931e-04 |
0.0 |
ITGB2 |
Cell-Cell Contact |
KEGG: hsa04514 |
| NK,cells(Nos)_source |
ITGB2_ligand |
HSC(Nos)_target |
ICAM2_receptor |
2.888e-04 |
0.0 |
ITGB2 |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
MPZL1_ligand |
HSC(Nos)_target |
MPZL1_receptor |
1.954e-04 |
0.0 |
MPZ |
Cell-Cell Contact |
KEGG: hsa04514 |
| Monocytes(Nos)_source |
PECAM1_ligand |
HSC(Nos)_target |
PECAM1_receptor |
1.967e-04 |
0.0 |
PECAM1 |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
PECAM1_ligand |
Monocytes(Nos)_target |
PECAM1_receptor |
1.967e-04 |
0.0 |
PECAM1 |
Cell-Cell Contact |
KEGG: hsa04514 |
| Monocytes(Nos)_source |
PECAM1_ligand |
Monocytes(Nos)_target |
PECAM1_receptor |
4.367e-05 |
0.0 |
PECAM1 |
Cell-Cell Contact |
KEGG: hsa04514 |
| HSC(Nos)_source |
SELL_ligand |
HSC(Nos)_target |
CD34_receptor |
1.203e-03 |
0.0 |
SELL |
Cell-Cell Contact |
PMID: 7692600; PMID: 8977216 |
| Monocytes(Nos)_source |
SELL_ligand |
HSC(Nos)_target |
CD34_receptor |
2.093e-04 |
0.0 |
SELL |
Cell-Cell Contact |
PMID: 7692600; PMID: 8977216 |